Updates on the preoperative immunotherapy for triple-negative breast cancer

Hong Hu; Virginia Kaklamani

doi:10.21037/tbcr-23-16

Updates on the preoperative immunotherapy for triple-negative breast cancer

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Article number	17
Journal	Translational Breast Cancer Research
Volume	4
DOIs	https://doi.org/10.21037/tbcr-23-16
State	Published - Apr 30 2023
Externally published	Yes

Keywords

Triple negative breast cancer (TNBC)
immunotherapy
neoadjuvant
pembrolizumab

ASJC Scopus subject areas

Oncology
Surgery

Access to Document

10.21037/tbcr-23-16

Cite this

@article{c0f39b12a2d84fb6bc5d88893cdbe79a,

title = "Updates on the preoperative immunotherapy for triple-negative breast cancer",

keywords = "Triple negative breast cancer (TNBC), immunotherapy, neoadjuvant, pembrolizumab",

author = "Hong Hu and Virginia Kaklamani",

year = "2023",

month = apr,

day = "30",

doi = "10.21037/tbcr-23-16",

language = "English (US)",

volume = "4",

journal = "Translational Breast Cancer Research",

issn = "2218-6778",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Updates on the preoperative immunotherapy for triple-negative breast cancer

AU - Hu, Hong

AU - Kaklamani, Virginia

PY - 2023/4/30

Y1 - 2023/4/30

KW - Triple negative breast cancer (TNBC)

KW - immunotherapy

KW - neoadjuvant

KW - pembrolizumab

UR - http://www.scopus.com/inward/record.url?scp=85206565557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85206565557&partnerID=8YFLogxK

U2 - 10.21037/tbcr-23-16

DO - 10.21037/tbcr-23-16

M3 - Editorial

AN - SCOPUS:85206565557

SN - 2218-6778

VL - 4

JO - Translational Breast Cancer Research

JF - Translational Breast Cancer Research

M1 - 17

ER -

Updates on the preoperative immunotherapy for triple-negative breast cancer

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this